ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ADMA Adma Biologics Inc

6.525
-0.055 (-0.84%)
최종 업데이트: 22:33:43
15분 지연
기업명 주식 심볼 시장 주식 타입
Adma Biologics Inc ADMA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.055 -0.84% 6.525 22:33:43
개장가 저가 고가 종가 전일 종가
6.51 6.50 6.56 6.58
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/03/202405:05EDGAR2Form 8-K - Current report
12/03/202401:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/03/202420:00GLOBEADMA Biologics Announces FDA Approvals of Extended Room..
09/03/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:05EDGAR2Form 8-K - Current report
05/03/202421:00GLOBEADMA Biologics to Participate in the Raymond James..
05/03/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202406:21EDGAR2Form 8-K - Current report
29/02/202406:15EDGAR2Form 8-K - Current report
29/02/202406:10GLOBEADMA Biologics Announces CFO Transition
29/02/202406:05GLOBEADMA Biologics Announces Fourth Quarter and Full Year 2023..
28/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:05GLOBEADMA Biologics to Report Fourth Quarter and Full Year 2023..
21/02/202422:00EDGAR2Form 8-K - Current report
21/02/202421:00GLOBEADMA Biologics Successfully Implements Innovative AI..
15/02/202401:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/01/202422:00EDGAR2Form 8-K - Current report
08/01/202421:30EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEADMA Biologics Announces Preliminary Fourth Quarter 2023..
06/01/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:05GLOBEADMA Biologics Announces $135 Million Non-Dilutive..
13/12/202306:30EDGAR2Form 8-K - Current report
12/12/202321:00GLOBEADMA Biologics Announces FDA Approval for BIVIGAM® in the..
17/11/202306:31EDGAR2Form 8-K - Current report
16/11/202321:00GLOBEADMA BioCenters Receives FDA Approval for its Tenth Plasma..
09/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:36EDGAR2Form 8-K - Current report
09/11/202306:05GLOBEADMA Biologics Announces Third Quarter 2023 Financial..
01/11/202320:00GLOBEADMA Biologics to Report Third Quarter 2023 Financial..
04/10/202310:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202305:45EDGAR2Form 8-K - Current report
31/08/202305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/08/202308:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202306:09EDGAR2Form 144 - Report of proposed sale of securities
19/08/202310:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/08/202301:58EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
18/08/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202309:47EDGAR2Form 144 - Report of proposed sale of securities
10/08/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:15EDGAR2Form 8-K - Current report
10/08/202305:05GLOBEADMA Biologics Announces Second Quarter 2023 Financial..
02/08/202320:00GLOBEADMA Biologics to Report Second Quarter 2023 Financial..
19/07/202320:30EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock